Cargando…

Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak

BACKGROUND: As the primary burden of treating COVID-19 patients began to ease in the United Kingdom, ophthalmology clinic volume within the National Health Service has since recovered. Alarmingly, the rate of non-attendance remains higher than the pre-pandemic level. PURPOSE: The purpose was to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Siyin, Ng, Jonathan K.Y., Moon, Emily Haejoon, Morgan, Daisy, Woodhouse, Natalie, Agrawal, Dakshita, Chan, Laura, Chhabra, Ramandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808017/
https://www.ncbi.nlm.nih.gov/pubmed/35128306
http://dx.doi.org/10.1177/25158414211070881
_version_ 1784643793967906816
author Liu, Siyin
Ng, Jonathan K.Y.
Moon, Emily Haejoon
Morgan, Daisy
Woodhouse, Natalie
Agrawal, Dakshita
Chan, Laura
Chhabra, Ramandeep
author_facet Liu, Siyin
Ng, Jonathan K.Y.
Moon, Emily Haejoon
Morgan, Daisy
Woodhouse, Natalie
Agrawal, Dakshita
Chan, Laura
Chhabra, Ramandeep
author_sort Liu, Siyin
collection PubMed
description BACKGROUND: As the primary burden of treating COVID-19 patients began to ease in the United Kingdom, ophthalmology clinic volume within the National Health Service has since recovered. Alarmingly, the rate of non-attendance remains higher than the pre-pandemic level. PURPOSE: The purpose was to assess how the perceived risk of contracting coronavirus disease 2019 (COVID-19) influences the willingness of individuals with sight-threatening macular conditions to attend intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection appointments during the second wave of the pandemic. METHODS: This prospective cross-sectional survey was conducted at the Macular Treatment Centre, Manchester Royal Eye Hospital. Patients who missed their appointment in January 2021 were invited to complete an anonymous survey over the telephone. The survey consisted of two parts: (1) a 23-item questionnaire aiming to assess fear of contracting COVID-19 in different hospital-related settings; and (2) the validated COVID-19 Anxiety Syndrome Scale (C-19ASS) to evaluate COVID-19-related anxiety. RESULTS: A total of 104 patients agreed to participate in the survey. Only a small proportion of patients believed COVID-19 vaccination (23 out of 88, 26.1%) had influenced their willingness to attend injection appointments. Majority of patients felt concerned about contracting COVID-19 during hospital appointments (n = 63, 60.6%). Only a minority of patients (n = 36, 34.6%) agreed with the hospital guidance on minimising clinical examinations during clinic visit. The C-19ASS was significantly higher in female patients, those older than 70 years and those with mobility issues. Higher C-19ASS, older age and living alone were predictors of clinic nonattendance. CONCLUSION: COVID-19 anxiety and fear of viral exposure could adversely affect patient adherence to clinic appointments during the pandemic. Particular attention should be provided to older patients, those who live alone and patients with impaired mobility. This is particularly relevant as hospital eye services across the world are in the process of restarting.
format Online
Article
Text
id pubmed-8808017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-88080172022-02-03 Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak Liu, Siyin Ng, Jonathan K.Y. Moon, Emily Haejoon Morgan, Daisy Woodhouse, Natalie Agrawal, Dakshita Chan, Laura Chhabra, Ramandeep Ther Adv Ophthalmol Original Research BACKGROUND: As the primary burden of treating COVID-19 patients began to ease in the United Kingdom, ophthalmology clinic volume within the National Health Service has since recovered. Alarmingly, the rate of non-attendance remains higher than the pre-pandemic level. PURPOSE: The purpose was to assess how the perceived risk of contracting coronavirus disease 2019 (COVID-19) influences the willingness of individuals with sight-threatening macular conditions to attend intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection appointments during the second wave of the pandemic. METHODS: This prospective cross-sectional survey was conducted at the Macular Treatment Centre, Manchester Royal Eye Hospital. Patients who missed their appointment in January 2021 were invited to complete an anonymous survey over the telephone. The survey consisted of two parts: (1) a 23-item questionnaire aiming to assess fear of contracting COVID-19 in different hospital-related settings; and (2) the validated COVID-19 Anxiety Syndrome Scale (C-19ASS) to evaluate COVID-19-related anxiety. RESULTS: A total of 104 patients agreed to participate in the survey. Only a small proportion of patients believed COVID-19 vaccination (23 out of 88, 26.1%) had influenced their willingness to attend injection appointments. Majority of patients felt concerned about contracting COVID-19 during hospital appointments (n = 63, 60.6%). Only a minority of patients (n = 36, 34.6%) agreed with the hospital guidance on minimising clinical examinations during clinic visit. The C-19ASS was significantly higher in female patients, those older than 70 years and those with mobility issues. Higher C-19ASS, older age and living alone were predictors of clinic nonattendance. CONCLUSION: COVID-19 anxiety and fear of viral exposure could adversely affect patient adherence to clinic appointments during the pandemic. Particular attention should be provided to older patients, those who live alone and patients with impaired mobility. This is particularly relevant as hospital eye services across the world are in the process of restarting. SAGE Publications 2022-01-31 /pmc/articles/PMC8808017/ /pubmed/35128306 http://dx.doi.org/10.1177/25158414211070881 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Liu, Siyin
Ng, Jonathan K.Y.
Moon, Emily Haejoon
Morgan, Daisy
Woodhouse, Natalie
Agrawal, Dakshita
Chan, Laura
Chhabra, Ramandeep
Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
title Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
title_full Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
title_fullStr Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
title_full_unstemmed Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
title_short Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
title_sort impact of covid-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808017/
https://www.ncbi.nlm.nih.gov/pubmed/35128306
http://dx.doi.org/10.1177/25158414211070881
work_keys_str_mv AT liusiyin impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak
AT ngjonathanky impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak
AT moonemilyhaejoon impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak
AT morgandaisy impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak
AT woodhousenatalie impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak
AT agrawaldakshita impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak
AT chanlaura impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak
AT chhabraramandeep impactofcovid19associatedanxietyontheadherencetointravitrealinjectioninpatientswithmaculardiseasesayearaftertheinitialoutbreak